SEC Form 4 · accession 0001179110-15-015445
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard James Whitley
Director
Period of report
Nov 20, 2015
Accepted (ET)
Nov 25, 2015 · 2:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF3 | Nov 20, 2015 | S | 5,514 | $106.9853 | D | 33,751 | D | |
| Common StockF2 | Nov 23, 2015 | S | 2,863 | $107.1762 | D | 30,888 | D | |
| Common Stock | Nov 24, 2015 | S | 169 | $106.4789 | D | 30,719 | D | |
| Common StockF1 | Nov 24, 2015 | G | 7,050 | — | D | 23,669 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares gifted to charitable entities.
- F2Sale prices reported for the transactions reported here range from $107.11 to $107.19. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F3Sale prices reported for the transactions reported here range from $106.98 to $106.99. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.